Dachaigh › Siostam Immune agus Galaran › New York › New York City
Sgrùdaidhean clionaigeach Siostam Immune agus Galaran ann an New York City, NY
Tha 12 sgrùdaidhean airson Siostam Immune agus Galaran a’ lorg phàirtichean aig làraichean ann agus timcheall air New York City (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
A’ fastadhÌre 1/2
- Mt Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
A’ fastadhÌre 1
- Memorial Sloan Kettering Cancer Center, New York
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
A’ fastadhÌre 3
- Memorial Sloan Kettering Cancer Center, New York
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
A’ fastadhÌre 3
- Memorial Sloan Kettering Cancer Center, New York
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
A’ fastadhÌre 1/2
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Abatacept for the Treatment of Giant Cell Arteritis
A’ fastadhÌre 3
- Hospital for Special Surgery, New York
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
A’ fastadhÌre 3
- Icahn School of Medicine at Mount Sinai, New York
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
A’ fastadhÌre 2
- Inmagene Site 21, New York
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
A’ fastadhÌre 2
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
A’ fastadhÌre 2
- Columbia University Irving Medical Center, New York
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
A’ fastadhÌre 1/2
- Columbia University, New York
Biologics And Clinical Immunology Cohort at Sinai
A’ fastadhSgrùdadh amharc
- Mount Sinai, New York
Sgrùdaidhean Siostam Immune agus Galaran ann am bailtean eile
- Washington, DC13 sgrùdaidhean
- Boston, MA10 sgrùdaidhean
- Philadelphia, PA10 sgrùdaidhean
- Atlanta, GA9 sgrùdaidhean
- Portland, OR9 sgrùdaidhean
- Houston, TX9 sgrùdaidhean
- Chicago, IL8 sgrùdaidhean
- Cleveland, OH8 sgrùdaidhean
- Los Angeles, CA8 sgrùdaidhean
- Seattle, WA6 sgrùdaidhean
- Cedar Rapids, IA6 sgrùdaidhean
- Milwaukee, WI6 sgrùdaidhean
Sgrùdaidhean eile ann an New York City
- Aillse a' bhroilleach137 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag121 sgrùdaidhean
- Aillse (gach seòrsa)110 sgrùdaidhean
- Aillse Prostata102 sgrùdaidhean
- Ailse metastatach93 sgrùdaidhean
- Aillse colorectal78 sgrùdaidhean
- Cancer Ovarian70 sgrùdaidhean
- Cancer Pancreatic60 sgrùdaidhean
- Myeloma iomaill60 sgrùdaidhean
- Ailseachadh nan Sgamhan60 sgrùdaidhean
- Ailse Endometrial52 sgrùdaidhean
- Fàilligeadh a' Chridhe51 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 7 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.